Specialty distribution and provider platforms drove September-quarter profit gains at the Big Three as brand pricing weighed on results.
Siloed pricing, contracting and affordability decisions can undercut a launch. IQVIA experts explain how system-level modeling surfaces trade-offs early.
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean ...
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Octapharma USA's Kerem Tokel, a LogiPharma USA 2026 freight security panelist, discusses theft hotspots, the export of stolen pharmaceutical loads and how to tighten chain of custody.
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
ELPRO CEO Frederik Dresen explains how cold chain monitoring moved from compliance to risk management, and what biologics and advanced therapies demand. The pharmaceutical cold chain has evolved from ...
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Emerging biotechs and large pharma companies start a launch from different positions. Jon Hamrick, partner at Curatio Advisors, explains how his firm profiles each therapy against a set of product ...
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results